Caricamento...
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
Elevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are ch...
Salvato in:
| Pubblicato in: | Cardiovasc Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587798/ https://ncbi.nlm.nih.gov/pubmed/30358114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1755-5922.12471 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|